Something is missing in this company and I cannot put my finger on it. Is it the Board composition that is detracting from being investor appealing, is it Pat Avery as Executive Chairman with more of a sales focus than a company strategy and risk focus, is it the low market liquidity is keeping interest away or it something else...
Maybe it is just the quarterly's constantly showing the COGS are too high for the revenue and scale will not redress it, in the foreesable future.
Beats me.
Ann: Fertoz Partnering Progress and Operational Delivery, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
